
About Ellodi Pharmaceuticals
Ellodi Pharmaceuticals is a Healthcare company based in Ewing Township (United States) founded in 2020. Therapeutics for Eosinophilic Esophagitis are developed by Ellodi Pharmaceuticals. Ellodi Pharmaceuticals offers products and services including APT-1011 and FLUTE 3 Study. Its focus areas include Life Sciences, Rare Diseases, Drugs and GI. Its competitors include Phathom Pharmaceuticals and Lumena Pharma; 2 of its 2 listed competitors have raised funding.
Company details
Ellodi Pharmaceuticals was founded in 2020 and is based in Ewing Township, United States. Focus is placed on the pharmaceutical sector, specifically gastroenterology, where therapeutics for disorders like Eosinophilic Esophagitis are developed. Proprietary orally disintegrating tablets, including APT-1011 and Esomeprazole ODT, are offered to address gastrointestinal conditions and rare chronic allergic inflammatory diseases. Operations center on research and product innovation for these targeted health issues.
- Headquarters Ewing Township, United States
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website ellodipharma.com
- Social LinkedIn
Products & Services of Ellodi Pharmaceuticals
Ellodi Pharmaceuticals offers a comprehensive portfolio of products and services, including APT-1011 and FLUTE 3 Study.
Novel treatment for Eosinophilic Esophagitis through clinical development
Research study evaluating therapies for Eosinophilic Esophagitis patients
Competitors of Ellodi Pharmaceuticals
Ellodi Pharmaceuticals has 2 listed competitors in our database, 2 of them funded. They include Phathom Pharmaceuticals and Lumena Pharma.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| phathompharma.com | 2019 | Menlo Park, United States | $90M | 113 | Therapies for gastrointestinal diseases are developed by Phathom Pharmaceuticals. | |
| lumenapharma.com | 2011 | San Diego, United States | $71.05M | 11 | Passionately pursuing better treatments for adults and children with rare liver diseases. |
Detailed competitors of Ellodi Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Rare Diseases
3 companies that operate in the same segment as Ellodi Pharmaceuticals (Rare Diseases) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ellodi Pharmaceuticals
Complete news archive for Ellodi Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ellodi Pharmaceuticals
Ellodi Pharmaceuticals was founded in 2020.
Ellodi Pharmaceuticals is headquartered in Ewing Township, United States. It is registered at Ewing Township, New Jersey, United States.
Ellodi Pharmaceuticals was founded in 2020 and is based in Ewing Township, United States. Focus is placed on the pharmaceutical sector, specifically gastroenterology, where therapeutics for disorders like Eosinophilic Esophagitis are developed. Proprietary orally disintegrating tablets, including APT-1011 and Esomeprazole ODT, are offered to address gastrointestinal conditions and rare chronic allergic inflammatory diseases. Operations center on research and product innovation for these targeted health issues.
Ellodi Pharmaceuticals's top competitors include Phathom Pharmaceuticals and Lumena Pharma.
Ellodi Pharmaceuticals offers APT-1011 and FLUTE 3 Study.
